Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Perampanel in Primary Generalized Tonic-Clonic Seizures
jRCT2080221732Phase 3
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2012
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Perampanel adjunctive therapy with Placebo adjunctive therapy (2 arms).
02
Drugs
perampanel
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2080221732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221732.